Tc Biopharm Plc Stock Last Dividend Paid

TCBPW Stock

USD 0.02 0 24.67%

TC BioPharm plc fundamentals help investors to digest information that contributes to TC BioPharm's financial success or failures. It also enables traders to predict the movement of TCBPW Stock. The fundamental analysis module provides a way to measure TC BioPharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TC BioPharm stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

TC BioPharm plc Company Last Dividend Paid Analysis

TC BioPharm's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

TCBPW Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for TC BioPharm is extremely important. It helps to project a fair market value of TCBPW Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since TC BioPharm's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TC BioPharm's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TC BioPharm's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Short Long Term Debt
Total Assets		0.47	0.05	-0.49	0.23	-0.38	0.6	-0.26	0.41	0.62	0.18	0.53	-0.46	-0.3	0.53	-0.15
Total Stockholder Equity	0.47		-0.54	-0.97	-0.1	-0.03	0.02	-0.96	0.96	0.44	-0.03	0.9	-0.89	0.15	0.0	-0.55
Current Deferred Revenue	0.05	-0.54		0.43	0.85	-0.78	0.68	0.49	-0.74	-0.53	0.81	-0.15	0.12	-0.81	0.71	0.91
Net Debt	-0.49	-0.97	0.43		0.06	0.13	-0.01	0.94	-0.91	-0.47	-0.02	-0.87	0.88	-0.15	0.0	0.53
Retained Earnings	0.23	-0.1	0.85	0.06		-0.88	0.87	0.06	-0.37	-0.54	0.99	0.34	-0.35	-0.96	0.91	0.87
Accounts Payable	-0.38	-0.03	-0.78	0.13	-0.88		-0.76	0.0	0.22	0.39	-0.9	-0.39	0.43	0.86	-0.78	-0.68
Net Receivables	0.6	0.02	0.68	-0.01	0.87	-0.76		0.06	-0.2	-0.18	0.81	0.41	-0.36	-0.92	0.99	0.67
Total Liab	-0.26	-0.96	0.49	0.94	0.06	0.0	0.06		-0.9	-0.3	-0.03	-0.87	0.88	-0.17	0.05	0.48
Net Invested Capital	0.41	0.96	-0.74	-0.91	-0.37	0.22	-0.2	-0.9		0.58	-0.31	0.74	-0.72	0.4	-0.23	-0.75
Total Current Assets	0.62	0.44	-0.53	-0.47	-0.54	0.39	-0.18	-0.3	0.58		-0.58	0.15	-0.1	0.54	-0.26	-0.78
Capital Stock	0.18	-0.03	0.81	-0.02	0.99	-0.9	0.81	-0.03	-0.31	-0.58		0.4	-0.43	-0.94	0.86	0.83
Net Working Capital	0.53	0.9	-0.15	-0.87	0.34	-0.39	0.41	-0.87	0.74	0.15	0.4		-0.99	-0.3	0.41	-0.13
Short Term Debt	-0.46	-0.89	0.12	0.88	-0.35	0.43	-0.36	0.88	-0.72	-0.1	-0.43	-0.99		0.28	-0.37	0.11
Intangible Assets	-0.3	0.15	-0.81	-0.15	-0.96	0.86	-0.92	-0.17	0.4	0.54	-0.94	-0.3	0.28		-0.94	-0.87
Common Stock	0.53	0.0	0.71	0.0	0.91	-0.78	0.99	0.05	-0.23	-0.26	0.86	0.41	-0.37	-0.94		0.72
Short Long Term Debt	-0.15	-0.55	0.91	0.53	0.87	-0.68	0.67	0.48	-0.75	-0.78	0.83	-0.13	0.11	-0.87	0.72

Click cells to compare fundamentals

Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.

Competition

Predict TC BioPharm

TCBPW Dividend Paid And Capex Coverage Ratio

Dividend Paid And Capex Coverage Ratio

(100.33)

At this time, TC BioPharm's Dividend Paid And Capex Coverage Ratio is fairly stable compared to the past year.

Based on the recorded statements, TC BioPharm plc has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Idea Analyzer Now

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas

All Next

Launch Module

TCBPW Fundamentals

	Return On Equity	-12.17
	Return On Asset	-1.09
	Number Of Shares Shorted	529
	EBITDA	(13.61 M)
	Net Income	(5.91 M)
	Cash And Equivalents	1.55 M
	Cash Per Share	0.08 X
	Total Debt	1.8 M
	Current Ratio	0.18 X
	Book Value Per Share	3.38 X
	Cash Flow From Operations	(10.54 M)
	Earnings Per Share	(0.75) X
	Number Of Employees	41
	Beta	0.25
	Total Asset	8.93 M
	Retained Earnings	(38.84 M)
	Working Capital	950.33 K
	Net Asset	8.93 M

About TC BioPharm Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze TC BioPharm plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TC BioPharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TC BioPharm plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for TCBPW Stock Analysis

When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC